Sanofi-Aventis has had to take Inyx USA to court after it failed to
deliver on a contract manufacturing and supply agreement, a
situation that Aventis feared could "seriously harm its
interests". There may be important lessons...
Applied Biosystems (ABI) saw 5 per cent revenue growth during its
first quarter of fiscal 2008 as sister company Celera posted
revenue growth of 57 per cent.
Swiss pharma Novartis today announced the largest manufacturing investment in its history, revealing plans for a $700m (€486.5m) biotech facility to be built alongside its new solid dose plant in the low cost, high quality biopharma hub of Singapore.
GlaxoSmithKline (GSK) is planning to strip itself down closer to
the bare bones of the business through further outsourcing and
offshoring, with hopes of making itself into a lean, mean, pharma
machine.
Sigma-Aldrich continued its strong year with both revenues and
pre-tax profits showing strong double-digit growth in the third
quarter predicting it will break the $2bn (€1.4bn) revenue mark
this year.
Illumina's third quarter revenues soared 82 per cent while
Affymetrix looked to bolster its slice of the genetics market by
filing more patent infringement claims against the young pretender.
Scanning probe microscope (SPM) maker, JPK Instruments has been
named as Germany's fastest growing nanotechnology company in
accounting firm Deloitte's 'Technology Fast 50'.
As it faces an increasingly uncertain financial future, Pfizer's
reaffirmation that it plans to retain its focus on cutting costs,
including outsourcing and offshoring, comes as no 'Kindler
surprise', unlike the firm's...
Illumina has released a new microRNA (miRNA) assay for gene
expression profiling at a cost that the company believes is less
than half that of other commercially available systems.
Scanning probe microscope maker Veeco has seen its third quarter
revenues drop 13 per cent to $97.7m (€68.7m) and plans to make 100
staff redundant as part of a restructuring drive.
Inyx Pharma has been given a new lease on life after it was bought by another UK firm, bringing relief after it was dragged into administration when its US parent company Inyx Inc. ran aground financially.
King Pharmaceuticals last week announced that it would be cutting
20 per cent of its workforce after the US Court of Appeals reversed
a previous court ruling and invalidated a patent covering the
firm's blood pressure drug, Altace...
We've all cringed at stories of people dumping their partners via
text message but in the world of business, Pfizer seems to have
taken things to a new level when its Exubera partners were
allegedly left to find out the product...
A new solid-state proton NMR (nuclear magnetic resonance) technique
has been developed that can quickly determine polymorphism of
active pharmaceuticals within tablet formulations.
LabTechnologist.com brings you its periodic update of recent
product releases, with additions from Activotec, Applied Biosystems
/ MDS Sciex, FEI, Invitrogen, Mettler Toledo and Torrey Pines.
Agilent and BioTrove are collaborating to deliver ultra
high-throughput sample preparation and mass spectrometry (MS)
systems to speed the analysis of in vitro assays used in
drug development.
Pfizer revealed today that it is abandoning its once-touted
blockbuster Exubera, ending months of speculation as to whether the
fledging world-first inhalable insulin would sink or swim in the
fierce waters of pharma.
Growing demand has prompted tableting specialist Meldex
International, formerly BioProgress, to launch a new sales and
distribution hub in Germany, with the UK firm also announcing a new
manufacturing contract for its XGel film.
Avecia Biologics has signed a development and manufacturing deal
with US firm BaroFold, making use of the company's protein
processing technology to produce its lead interferon-based multiple
sclerosis (MS) candidate.
US-based contract manufacturer AMRI has been busily embracing India
with the purchase and construction of infrastructure to cement
itself in this popular location, delegates heard at this year's
CPhI in Milan.
Denmark-based Bavarian Nordic has received an advance payment of
$50m (€35.4m) from the US Government for meeting milestones in one
of its smallpox vaccine supply contracts.
UK-based TeraView has had its tablet imaging technology backed by
the US Food and Drug Administration (FDA), following a study by the
regulatory agency.
The European Fine Chemicals Group (EFCG) has called for stricter
regulation of pharmaceutical excipients in a bid to prevent
substandard and potentially dangerous products ending up in
medicinal drugs.
Denmark's Novo Nordisk, could be on the verge of selling off its
engineering division, if reports in the local business daily Borsen
are to be believed.
Amgen has announced the 'indefinite postponement' on plans for its
$1bn (€0.71bn) manufacturing facility in Cork, Ireland, following
further navel gazing by the company.
German pharma firm Bayer is currently discussing with Indian
company Biocon about a potential deal that would include the
co-development of new biologics with an outsourcing element,
according to Biocon.
SAFC has announced its plans to build a new high potency
conjugation suite at its Missouri manufacturing plant in order to
target pharma clients developing novel anti-cancer drug conjugates.
Applied Biosystems (ABI) has exclusively licensed Olink
Bioscience's proximity ligation assay (PLA) technology that enables
the correlation of gene and protein expression data.
LabTechnologist.com brings you a round up of recent industry news,
with developments at Affymetrix, Celera, deltaDOT, Eksigent,
Farfield, Nanogen and Olympus UK.
Discovery Laboratories could see the end of its struggle to launch
its Surfaxin (lucinactant) drug on the US market as it has finally
resolved the manufacturing issues that have plagued the product for
months.
Pharmaceutical companies not only have to face the consequences of
a burgeoning counterfeit drug black market but have to contend with
the theft of their own manufactured drugs for illicit uses,
according to a US consumer advocacy...
Novartis has hooked up with the Massachusetts Institute of
Technology (MIT) to fund a project aimed at 'revolutionising'
pharmaceutical manufacturing and doing away with traditional
batch-based production techniques.
Waters and Thar Instruments have agreed to deepen their
collaboration to combine their strengths in mass spectrometry (MS)
and super critical fluid chromatography (SFC) to make separation
science 'greener'.
Dutch firm Crucell is hastily trying to reassure investors that its
popular cell line technology, PER.C6, was not to blame for the
failure of Merck's hotly touted HIV vaccine last week.
Wyatt Technologies has launched a new instrument that automates
protein aggregation measurement for use in all areas of the
pharmaceutical industry from drug development to quality control
(QC).
Following the recent news that pharma heavyweight Pfizer has also
been struck by contamination of its HIV drug Viracept (nelfinavir),
in-PharmaTechnologist.com spoke to the US Food and Drug
Administration (FDA) to find out how far...
